Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision.
Baxter manufactures products in 26 countries and sells them in more than 100 countries, with approximately 60 percent of its sales coming from outside the United States. Baxter subsidiaries in approximately 40 countries employ their own sales forces, while sales in other countries are made through independent distributors or sales agents. In 2008, Baxter’s global sales totaled approximately $12.3 billion. At year-end 2008, Baxter employed approximately 48,500 people worldwide. Visit Baxter's Web site for more information[1].
Baxter is a member of the Pew Center on Global Climate Change Business Environmental Leadership Council, a group of major companies that demonstrate leadership by establishing and meeting greenhouse gas emissions reduction targets; investing in more efficient products, practices and technologies; and supporting domestic and international action to achieve cost-effective emissions reductions. Read the guiding principles[2] of the Business Environmental Leadership Council.
Baxter's Greenhouse Gas Reduction Targets:
Reduce greenhouse gas emissions 45 percent indexed to revenue from 2005 baseline (by 2015).
Increase facility energy usage of renewable power to 20 percent of total (by 2015).
“We strive to be leaders in all of our sustainability-related activities, whether it’s corporate giving, expanding access to healthcare, reducing our environmental impact or other areas.We are as committed to helping solve today’s global sustainability challenges as we are to developing better products and therapies for patients.” Robert L. Parkinson, Jr., CEO and Chairman, Baxter
Baxter[7] is a member of the Business Environmental Leadership Council (BELC), the largest U.S.-based association of companies dedicated to business and policy solutions to climate change. Baxter is a global medical products and services company, which provides therapies for people with life-threatening conditions. The company’s products and services include bioscience (biopharmaceuticals, vaccines, bio-surgery and transfusion therapies), and medication delivery and renal therapy, and are used by health-care providers and their patients in more than 100 countries.